Le Lézard
Classified in: Health, Covid-19 virus
Subjects: CHI, PDT, DEI

Banty Presents Successful COVID-19 Educational Event 'Let Kids Be Kids'


TORONTO, Jan. 21, 2022 /PRNewswire/ -- On Wednesday, January 19, video conferencing solution and virtual live event producer, Banty Inc., presented Let Kids Be Kids, an online educational gathering focused on COVID-19's impact on children.

Let Kids Be Kids featured a detailed and informative presentation from Dr. Martha Fulford (Infectious Diseases Physician and Associate Professor at McMaster University; Chief of Medicine for the McMaster University Medical Centre - Hamilton Health Sciences), as well as compelling commentary from Dr. Khrista Boylan (Pediatric Psychiatrist and Associate Professor, Department of Psychiatry & Behavioural Neurosciences at McMaster University), as well as moderators Dr. Richard Tytus (Family Doctor; Associate Clinical Professor, Family Medicine at McMaster University) and Dr. Dennis DiValentino (Family Doctor; Assistant Clinical Professor, Family Medicine at McMaster University).

The event touched on several important issues including the mental and emotional toll COVID-19 restrictions have had on children; whether or not schools should continually remain open during the pandemic; and vaccinations.

Separate sessions were held for healthcare professionals and the general public alike. These sessions attracted an international audience of 500+, more than half of which came from the healthcare industry. Together they actively took part in the conversation, thanks to the interactive Q&A discussions moderated by Banty.

In the near-term, Banty will make footage from the Let Kids Be Kids event available online. This will ensure that the significant dialogue featured during this gathering will have the opportunity to live on for years to come.

"I could not be happier with how Let Kids Be Kids turned out," offers Dr. Tytus. "All panelists involved brought with them wonderful pieces of information and insight regarding the impact COVID-19 has had on children. All of which was important for attendees to hear."

He continues: "Banty made it possible for Let Kids Be Kids to put forward a high-quality virtual event in a space that was both engaging and interactive. It cannot be overstated how crucial it is to have an entity like Banty available to healthcare professionals invested in putting forth educational online events."

About Banty

Founded in 2020, Banty offers exceptional video conferencing solutions for Businesses,Medical Practices and Virtual Events. Banty video conferencing is easy to use and ultra-secure. The platform provides users with a dedicated Banty.com URL, accessible via any desktop browser or through iOS and Android mobile apps.

In order to receive government approval to become a verified medical platform, Banty was upgraded to meet new cyber security standards, making it one of the most secure platforms available. Each day, the Banty team goes above and beyond to ensure the platform remains one of the most secure and innovative virtual meeting solutions in the world.

For more information, please visit Banty.org/solutions, or follow Banty on social media to learn more about the latest platform innovations: LinkedIn, Twitter, Facebook, YouTube, Instagram.

Media Contact:
Scott Wilson
289-259-8059
[email protected] 

SOURCE Banty Inc.


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: